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Abstract
We report the imaging of β-cyclodextrin/benzoic acid binding at 14T using hyperpolarized 13C
magnetic resonance (MR). Benzoic acid was polarized using a dynamic nuclear polarization
(DNP) approach and combined with β-cyclodextrin in aqueous solution. As anticipated, decreases
in the spin-lattice relaxation constant (T1) were observed with decreases in the ligand/ receptor
ratio. The calculated log K was approximately 1.7, similar to previously reported binding
constants. Hyperpolarized [1-13C] benzoic acid was used to interrogate solutions of variable β-
cyclodextrin concentration, with the mixtures imaged at 14T using a 3D frequency-selective MR
sequence. Differences in β-cyclodextrin concentration were easily visualized. These results
suggest that hyperpolarized 13C MR could be used in vivo to determine the presence, and density
of receptors for a given ligand-receptor pair.
At the core of modern pharmacotherapy is molecular recognition between small molecule
ligands and their protein targets (typically enzymes) in water. The hydrophobic effect is
critical in this process. The driving force for the hydrophobic phenomenon is primarily
entropic, where water must adopt an “organized” structure as it solvates non-polar
molecules, thereby reducing solvent entropy1. This effect has been studied extensively using
various complexes of β-cyclodextrin, a naturally occurring cyclic polysaccharide composed
of β-D-glucose residues linked through α-1,4 glycosidic bonds2. These molecules have been
of interest as a result of their amphiphilic nature: while the hydroxyl groups confer high
water solubility, the cyclic arrangement of sugars creates a hydrophobic cavity. The
cyclodextrin ligand-receptor system has been used to mimic a variety of interactions
between proteins and small molecules3-5. Here, we report the imaging of this model system
using hyperpolarized 13C MR, a technique that can be extended in vivo to a variety of
biomolecules relevant to the treatment of human disease.
Recent developments in the fields of low temperature physics, electron paramagnetic
resonance (EPR), and NMR have allowed the application of dynamic nuclear polarization
(DNP) to traditional liquids NMR6,7. This process typically requires the sample of choice to
exist as an amorphous solid at 1°K in the presence of a stable organic free radical. This
technique has been used to study in vivo metabolism by polarizing a metabolite, at close to
physiologic levels (in the mM range), and injecting it into a system to observe its
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conversion8-11 or distribution by MRI/MRSI7. Bench-top studies have also been conducted
to investigate ways the hyperpolarized signal can be used indirectly. These have focused on
observing other nuclei, typically 1H via direct bond12, or secondarily labeling a compound
by way of chemical reaction13.
It is still unclear how to interpret changes of hyperpolarized signal as a function of the
nuclear environment. The dominant force associated with decay of the hyperpolarized signal
is spin-lattice relaxation (or T1). The hyperpolarized signal of long T1 carbons lasts longer
and this signal can be converted into an ordered spin state using an appropriate pulse
sequence14. In most DNP studies, the T1 relaxation time is used as a parameter for
determining what spins to label and observe. The goal of this study was to use T1 relaxation
to understand the effect of hydrophobic binding on hyperpolarized signals, and use T1
changes to image a model ligand-receptor system in aqueous solution.
It is well known that in fast exchange systems, changes in parameters such as observed
magnetization, chemical shift, and spin relaxation rates (T1, T2, T1ρetc…) can be used to
estimate equilibrium constants such as the binding constant in a ligand-receptor system15. In
this case we used the well-characterized system of benzoic acid (ligand) and β-cyclodextrin
(receptor)16,17. In the presence of β-cyclodextrin, the aromatic ring of benzoic acid
preferentially inserts itself into the inner-core of the cyclodextrin molecule, confirmed by x-
ray crystallography (Figure 1a).18
To explore this system, samples of natural abundance benzoic acid were dissolved in
dimethylacetamide (DMA) to a concentration of 3.6M. 2mg of the Finland radical19 per
100mg of benzoic acid was used as the organic free radical. Prepared samples were
polarized for approximately 1 hour (at 94.094 Ghz) in a Hypersense® (Oxford Instruments,
Oxford UK) and dissolved in 5mL of 100 mM phosphate buffer (pH=7.8). For binding
studies, the hyperpolarized benzoic acid solution was mixed with 0.5mM β-cyclodextrin in
the same 100mM phosphate buffer. All NMR studies were conducted at 310K in a 10mm
broadband probe on a 500Mhz (125Mhz for 13C) Varian INOVA NMR spectrometer. All
data were acquired using a 5° flip angle and 3s repetition time. Apparent T1 relaxation times
were fit to a mono-exponential equation in Matlab (Mathworks) as previously
described13,20,21.
As seen in Figure 1b, all carbons of natural abundance benzoic acid were hyperpolarized,
observed and resolved in one 5° degree pulse at a concentration of 36.4mM.
Hyperpolarized benzoic acid was then mixed in increasing concentrations relative to 0.5 mM
β-cyclodextrin to assess the changes in T1. The hyperpolarized decay of the C1 and C2
carbons of benzoic acid, as well as the effect of changing the ligand-receptor ratio are shown
in Figure 2. Overall signal decreased more rapidly in time as a result of the interaction of the
benzoic acid carbons and β-cyclodextrin. For example, when benzoic acid β-cyclodextrin
were combined at concentrations of 36.4 and 0.5 mM respectively, the apparent T1
decreased from 34.9 s and 19 s to 28.8 s and 16.4 s for the C1 and C2 carbons. Increasing
concentrations of benzoic acid relative to a constant β-cyclodextrin were used to generate
the plot depicted in Figure 2b, where ΔObs is defined as 1/T1obs-1/T1free. The y-intercept of
the linear fit can be used to determine the log binding constant (log K) as a result of changes
in the observed T1 for the C1 and C215. The log K derived from the fits of the C1 and C2
changes were 1.74 and 1.68 respectively. These constants were within the range of reported
log K measurements of benzoic acid (1.5-2.2) interacting with β-cyclodextrin16. Due to
significantly lower T1, the hyperpolarized signal for the other benzoic acid carbons could
not be used for reliable T1 calculations. This approach was further extended to natural
abundance 2-naphthaleneacetic acid, 6-methoxy-α-methyl-sodium salt (naproxen), a drug
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used to treat inflammation that is a known β-cyclodextrin guest. For these studies, 6.5mM
hyperpolarized naproxen was mixed with 0.5 mM β-cyclodextrin. The T1 relaxation time of
the free naproxen C1 was 14.8 ± 0.3 secs (n=3) and when in the presence of the host was
reduced ∼30% to 10.6 ± 0.4 secs (n=3) (Supplementary Figure 1). The other carbons were
not observed in the presence of the cyclodextrin host, in keeping with previous work
showing loss of hyperpolarized 13C signal with binding22.
We hypothesized that benzoic acid- cyclodextrin binding could be used to create image
contrast in a 13C MR experiment at 14T. This strategy would take advantage of the T1-
dependent loss of hyperpolarized signal observed in the presence of the cyclodextrin
receptor, effectively creating negative contrast. A similar phenomenon would be expected in
vivo for a given ligand/ receptor pair. [1-13C] benzoic acid was polarized as described
previously for the natural abundance substrate. The enriched [1-13C] benzoic acid samples
were polarized to 10%, corresponding to a signal enhancement of approximately 9000-fold
at 14T. Imaging studies were performed on a 14T, 600WB micro-imaging spectrometer
equipped with 100G/cm gradients (Varian Instruments). For hyperpolarized 13C imaging, a
3D frequency-selective echo planar sequence was used to acquire a 3D image for [1-13C]
benzoic acid with an acquisition time of approximately 180ms23. The final concentration of
[1-13C] benzoic acid was 2.5 mM, combined with the β-cyclodextrin host at final
concentrations of 0.5, 2.5, and 10 mM. These results are described in Figure 3, with loss of
hyperpolarized 13C signal observed with increasing concentrations of β-cyclodextrin. Figure
3a shows both 1H and 13C imaging of the four cyclodextrin-containing solutions as well as a
5M [1-13C] benzoic acid phantom (in 6mm glass tubes). 1H gradient echo imaging reveals
similar signal for the five samples, while the hyperpolarized MR image shows diminished
signal corresponding to the concentration of the cyclodextrin host. The same 3D MR
sequence was used to image the tubes at equilibrium, with only the 13C benzoic acid
phantom visible. The 1H image was used to define regions of interest (ROI's) and the
mean 13C MR signal intensities for the cyclodextrin solutions were used to construct the
graph displayed in Figure 3b, providing a gross correlate to the T1 experiments conducted
previously.
In a typical modern 1H MRI exam, tissue contrast is obtained by differences between the
intrinsic T1 and T2 of various tissues. Our results suggest a new mechanism of MR contrast,
whereby changes in T1 of an administered hyperpolarized 13C probe can be correlated with
the concentration of a cellular target. As the arsenal of hyperpolarized 13C probes expands,
numerous ligand-receptor pairs relevant to the treatment of human disease may be
investigated simultaneously24, and non-invasively. In the context of a biologically relevant
ligand/ receptor pair, we would expect to observe T1- mediated loss of hyperpolarized signal
in the presence of receptor, that in many cases would be clinically significant. For
example, 13C steroid probes could be used to determine the estrogen/ progesterone receptor
status in patients with breast cancer, or predict response to anti-androgen therapy in prostate
cancer. This technique will benefit from the tighter binding seen in biologic systems,
allowing receptors at smaller concentrations to be interrogated.
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(a) Structure of the β-cyclodextrin- benzoic acid complex, as solved by X-ray
crystallography in 2003 by Aree et al. (b) 13C NMR spectrum of natural abundance
hyperpolarized benzoic acid, obtained in a single 5° pulse at 36.4 mM (310K, pH = 7.8). All
carbons are observed: C1-176.6 ppm, C2-137.3 ppm, C3,C7- 129.8 ppm, C4,C6- 129.3 ppm
and C5-132.2 ppm.
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(a) Hyperpolarized signal decay of the C1 carbon of benzoic acid without the β-cyclodextrin
host present (TR = 3 s, calculated T1 = 34.9 s at 11.7T). (b) Decay for the C2 carbon
(calculated T1 = 19.0 s) (c) Plot of [β-cyclodextrin]/ΔObs as a function of increased benzoic
acid [BA] concentration. The R2 of the C1 and C2 fits were 0.995 and 0.953 respectively.
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Hyperpolarized 13C MR imaging experiment conducted at 14T. (a) 1H imaging shows the
orientation of tubes containing variable β-cyclodextrin concentration (0–10 mM final
concentration). Also included is a [1-13C] benzoic acid phantom (5 M). The
hyperpolarized 13C MR imaging study was performed using a 3D frequency-selective
sequence after administration of hyperpolarized [1-13C] benzoic acid (final concentration
2.5 mM), and demonstrates loss of signal corresponding with increasing [β-cyclodextrin].(b)
Graph of hyperpolarized [1-13C] benzoic acid MR signals observed with variable [β-
cyclodextrin], quantified for the imaging experiment.
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